Source comparison
Comparison to Other Metabolic Peptides
MOTS-c AMPK activation, mitochondrial function Mitochondrial DNA Retatrutide GLP-1/GIP/glucagon triple agonism Synthetic incretin analog Tirzepatide GLP-1/GIP dual agonism Semaglutide GLP-1 receptor agonism SS-31 Cardiolipin binding, mitochondrial protection S
This comparison does not assign a generated winner or score.
- MOTS-c
- AMPK activation, mitochondrial function
- Mitochondrial DNA
- Retatrutide
- GLP-1/GIP/glucagon triple agonism
- Synthetic incretin analog
- Tirzepatide
- GLP-1/GIP dual agonism
- Semaglutide
- GLP-1 receptor agonism
- SS-31
- Cardiolipin binding, mitochondrial protection
- Synthetic mitochondrial-targeted
- The comparison highlights the mechanistic distinction: MOTS-c and SS-31 both act on mitochondrial biology but through different mechanisms, while GLP-1 class compounds work through incretin receptor signaling in the gut and pancreas. Researchers designing metabolic protocols should select the compound whose mechanism aligns with their research question. For deeper comparisons, see the SS-31 vs MOTS-c mitochondrial comparison and the GLP-1 class comparison guide.